Poster session 1
Virus and cancer

Programme

• • Poster Presentation
  • PP 174

  Fighting cancer – turning cold tumors into hot by rationally combining oncolytic viruses with immune-checkpoint inhibitors

  • Dr. Mariangela Garofalo (Padova / IT)

   Viral vectors, Virus and cancer
• • Poster Presentation
  • PP 175

  Herpesviridae – livelong companions in the spot light

  • Rosemarie Preyer (Strassberg / DE)

   Virus and cancer
• • Poster Presentation
  • PP 176

  Herpes simplex virus capsid mobility and transport through the chromatin labyrinth

  • Dr. Maija Vihinen-Ranta (Jyväskylä / FI)

   Virus and cancer
• • Poster Presentation
  • PP 177

  HTLV-1 retrovirus is not detected by dendritic cells and alters their response to a restimulation

  • Auriane Carcone (Lyon / FR)

   Virus and cancer
• • Poster Presentation
  • PP 178

  Memo1 is a novel cellular interacting partner of Human Papillomavirus E7

  • Oscar Trejo Cerro (Trieste / IT)

   Virus and cancer
• • Poster Presentation
  • PP 179

  The expression levels of MDM4, PSMD10, BIRC5 and c-MYC cellular genes increased following the presence of Epstein-Barr virus nuclear antigen 1 protein in HeLa cell line

  • Dr. Amir Hossein Alipour (Shiraz / IR)

   Virus and cancer, Virus-host interactions: entry, replication, assembly, egress
• • Poster Presentation
  • PP 180

  HPV type 18 E6 and E7 oncogene expression is elevated by Epstein-Barr virus nuclear antigen 1 in the HeLa cell line

  • Dr. Amir Hossein Alipour (Shiraz / IR)

   Virus and cancer, Virus-host interactions: entry, replication, assembly, egress
• • Poster Presentation
  • PP 181

  Effect of the G-patch domain of Mason-Pfizer monkey virus on the activity of cellular RNA helicase DHX15

  • Ivana Křížová (Prague / CZ)

   Virus and cancer
• • Poster Presentation
  • PP 182

  Characterization of Mason-Pfizer monkey virus reverse transcriptase

  • Larisa Šinkovec (Prague / CZ)

   Virus and cancer, Virus-host interactions: entry, replication, assembly, egress
• • Poster Presentation
  • PP 183

  Fate of the tegument proteins ORF52 and ORF45 upon de novo KSHV infection

  • Hanan Abu-Hassan (Maalot-Tarshiha / IL)

   Virus and cancer
• • Poster Presentation
  • PP 184

  Unidirectional recruitment is essential for viral latency

  • Professor Meir Shamay (Safed / IL)

   Virus and cancer, Virus-host interactions: entry, replication, assembly, egress
• • Poster Presentation
  • PP 185

  A single-nucleotide polymorphism in TLR9 is associated with a risk of ovarian cancer and higher CMV viraemia

  • Daria A. Haręża (Lodz / PL)

   Virus and cancer, Virus-host interactions: entry, replication, assembly, egress
• • Poster Presentation
  • PP 186

  Dual CMV and EBV infection in HSCT patient under antiviral therapy

  • Martyna Pociupany (Leuven / BE)

   Virus and cancer
• • Poster Presentation
  • PP 187

  Novel localization pattern of Human Cytomegalovirus (HCMV) IE1 protein on mitotic chromosomes

  • Mamata Savanagouder (Olsztyn / PL)

   Virus and cancer
• • Poster Presentation
  • PP 188

  A genome-wide CRISPR-Cas9 loss-of-function screening to identify novel host restriction genes contributing to oncolytic virotherapy resistance in pancreatic ductal adenocarcinoma

  • Dr. Michela Muscolini (Rome / IT)

   Viral vectors, Virus and cancer
• • Poster Presentation
  • PP 189

  Ev vivo response to latency reversal agents of CD4⁺ T cell subsets and monocyte derived HIV-1 subtype C LTR from individuals on suppressive cART

  • Kasmira Gopee (Durban / ZA)

   Virus and cancer
• • Poster Presentation
  • PP 190

  Development of a Nipah virus model of disease

  • Dr. Stephen Findlay-Wilson (Salisbury / GB)

   Virus and cancer, Virus-host interactions: entry, replication, assembly, egress